Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose-Reference-Cited by-同舟云学术

Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose

Published:2014-06-02 Issue:9 Volume:49 Page:1239-1240
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

dos Santos K B,Costa L J,Atalla A,Pereira J,Hallack-Neto A E

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2014121.pdf

Reference7 articles.

1. Visani G, Malerba L, Stefani PM, Capria S, Galieni P, Gaudio F et al. BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients. Blood 2011; 118: 3419–3425.

2. Chao NJ, Kastrissios H, Long GD, Negrin RS, Homing SJ, Wong RM et al. A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma. Cancer 1995; 75: 1354–1359.

3. Stuart MJ, Chao NS, Horning SJ, Wong RM, Negrin RS, Johnston LJ et al. Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory hodgkin’s disease. Biol Blood Marrow Transplant 2001; 7: 552–560.

4. Perz JB, Giles C, Szydlo R, O’Shea D, Sanz J, Chaidos A et al. LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin’s lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre. Bone Marrow Transplant 2007; 39: 41–47.

5. Ramzi M, Mohamadian M, Vojdani R, Dehghani M, Nourani H, Zakerinia M, Haghighinejad H . Autologous noncryopreserved hematopoietic stem cell transplant With CEAM as a modified conditioning regimen in patients with hodgkin lymphoma: a single-center experience with a new protocol. Exp Clin Transplant 2012; 10: 163–167.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross-allergic reactions between etoposide and penicillin in autologous bone marrow transplant patient;Iraqi Journal of Hematology;2022

2. Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients;Bone Marrow Transplantation;2021-11-29

3. Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non‐Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphoma;Transplant International;2020-07-23

4. LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow Transplantation;Frontiers in Oncology;2019-09-10

5. LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma;Bone Marrow Transplantation;2018-10-03